B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

KIFC1

MOLECULAR TARGET

kinesin family member C1

UniProt: Q9BW19NCBI Gene: 38332 compounds

KIFC1 (kinesin family member C1) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting KIFC1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate).0.691
2Adenosine Triphosphate0.691

About KIFC1 as a Drug Target

KIFC1 (kinesin family member C1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented KIFC1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

KIFC1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.